| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |